Record Revenue and Margin Performance PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financial results for the third quarter of 2024. Recent Highlights Revenues of $1.4 million in the first nine months of 2024, an increase of 51% compared to the same period of 2023.Gross margin percentages improved to 65% during Q3 2024 compared to

Significantly Expanding Market Reach PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a leader in fertility control solutions for managing animal pest populations, is excited to announce a significant expansion in the distribution of its groundbreaking rodent birth control product. Evolve™ Rat and Evolve™ Mouse are now available on Walmart Marketplace, one of the largest and most trusted eCommerce platforms in the world. SenesTech developed its proprietary technology for managing rat and mouse populations—through fert

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results. Third Quarter 2024 Conference Call Details Date and Time: Tuesday, November 12, 2024, at 5:00 pm ET Call-in Information: Interested parties can access th

PHOENIX, Oct. 31, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in birth control to manage rodent pest populations, today announces the successful registration of Evolve™ in Hong Kong. A Sustainable and Humane Approach to Rodent Control Hong Kong welcomes Evolve™, an innovative, non-lethal rodent birth control solution designed to target rat infestations at their root. Unlike conventional methods, Evolve restricts rodent reproduction, offering an effective and humane way to manage infestations without posing risks to humans, pets, wildlife, or the environment.

PHOENIX, Oct. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in birth control to manage rodent pest populations, today announces that the New York City Council has approved a bill to implement a rat contraception pilot program. From the bill, the term "rat contraceptive" means an agent for the reduction of reproductive capacity in rats that is approved for such use by the United States Environment Protection Agency. SenesTech is currently the only manufacturer of products that meet this requirement. This bill, Int. No. 736-A, mandates the Department of Healt

PHOENIX, Sept. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today it will participate in a webcasted presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2024 Investor Conference, taking place virtually on Tuesday, October 1, 2024. Company WebcastThe webcasted presentation will take place at 11:00am ET on Tuesday, October 1, 2024. The webcast can be accessed by visiting the conference home page at https://lyt

PHOENIX, Aug. 23, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of an exercise of certain existing warrants to purchase 505,502 shares of the Company's common stock at a reduced exercise price of $4.60 per share. In addition, the Company issued new warrants, as described below. The aggregate gross proceeds from the exercise of the existing warrants were approximately $2.3 million, before deducting placement agent fees and other offering expenses payable by the Company.

Record Revenue and Margin Performance PHOENIX, Aug. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the second quarter of 2024. Recent Highlights Record revenues of $874,000 in the first half of 2024, an increase of 62% compared to the first half of 2023.Gross margin percentages improved to 54% during Q2 2024 compared to 47% in Q1 2024

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 1, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its second quarter 2024, ended June 30, 2024, after the market close on Thursday, August 8, 2024. The Company has scheduled a conference call that same day, Thursday, August 8, 2024, at 5:00 pm ET, to review the results. Second Quarter 2024 Conference Call Details Date and Time: Thursday, August 8, 2024, at 5:00 pm ET Call-in Information: Interested parties can access the confere

LOS ANGELES, July 31, 2024 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The GotStocks Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The GotStocks Podcast puts the small-cap sector in the limelight with in-depth interviews featuring executives responsible for guiding gems that could be on the cusp of huge moves. The latest episode features Joel Fruendt, President and CEO of SenesTech Inc. (NASDAQ:SNES), the leader in fertility control to manage animal pest

Record Revenue and Margin Performance PHOENIX, Nov. 12, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), the leader in fertility control to manage animal pest populations and the only manufacturer of commercial and consumer available EPA-registered Rat Birth Control® products today announced financial results for the third quarter of 2024. Recent Highlights Revenues of $1.4 million in the first nine months of 2024, an increase of 51% compared to the same period of 2023.Gross margin percentages improved to 65% during Q3 2024 compared to

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Nov. 5, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on Tuesday, November 12, 2024. The Company has scheduled a conference call that same day, Tuesday, November 12, 2024, at 5:00 pm ET, to review the results. Third Quarter 2024 Conference Call Details Date and Time: Tuesday, November 12, 2024, at 5:00 pm ET Call-in Information: Interested parties can access th

Record Revenue and Margin Performance PHOENIX, Aug. 8, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the second quarter of 2024. Recent Highlights Record revenues of $874,000 in the first half of 2024, an increase of 62% compared to the first half of 2023.Gross margin percentages improved to 54% during Q2 2024 compared to 47% in Q1 2024

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 1, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its second quarter 2024, ended June 30, 2024, after the market close on Thursday, August 8, 2024. The Company has scheduled a conference call that same day, Thursday, August 8, 2024, at 5:00 pm ET, to review the results. Second Quarter 2024 Conference Call Details Date and Time: Thursday, August 8, 2024, at 5:00 pm ET Call-in Information: Interested parties can access the confere

PHOENIX, May 9, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), the leader in fertility control to manage animal pest populations and the only manufacturer of commercially available, EPA-registered Rat Birth Control® products today announced financial results for the first quarter of 2024. Recent Highlights Record quarterly revenues during Q1 2024 of $415,000, an increase of 78% compared to Q1 2023.Evolve™, formulated especially for the control of rat fertility and launched at the beginning of the year, has quickly become the Company'

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 2, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its first quarter 2024, ended March 31, 2024, after the market close on Thursday, May 9, 2024. The Company has scheduled a conference call that same day, Thursday, May 9, 2024, at 5:00 pm ET, to review the results. First Quarter 2024 Conference Call Details Date and Time: Thursday, May 9, 2024, at 5:00 pm ET Call-in Information: Interested parties can access the conference call by

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Feb. 15, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its fourth quarter and fiscal year 2023, ended December 31, 2023, after the market close on Wednesday, February 21, 2024. The Company has scheduled a conference call that same day, Wednesday, February 21, 2024, at 5:00 pm ET, to review the results. Fourth Quarter and Fiscal Year 2023 Conference Call Details Date and Time: Wednesday, February 21, 2024, at 5:00 pm ET Call-in Infor

July 2023 Sales Increased 126% as New Initiatives Take Hold Expanded Product Offerings Expected to Drive Future Growth PHOENIX, Aug. 10, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced financial results for the second quarter of 2023 for the period ended June 30, 2023. "We successfully executed against a number of key strategic imperatives to drive long-term growth in Co

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, Aug. 3, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on Thursday, August 10, 2023. The Company has scheduled a conference call that same day, Thursday, August 10, 2023, at 5:00 pm ET, to review the results. Second Quarter 2023 Conference Call Details Date and Time: Thursday, August 10, 2023, at 5:00 pm ET Call-in Information: Interested parties can access the conf

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 4, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on Thursday, May 11, 2023. The Company has scheduled a conference call that same day, Thursday, May 11, 2023, at 5:00 pm ET, to review the results. First Quarter 2023 Conference Call Details Date and Time: Thursday, May 11, 2023, at 5:00 pm ET Call-in Information: Interested parties can access the conference call